VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 1.42.
| Share Price | ₹736.0 | Jan 21,2026 |
| Market Cap | ₹986.2 Cr | |
| Sales-TTM | ₹696.5 Cr | TTM-Consolidated Results |
| Price/Sales | 1.42x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹986.2 Cr] as on Jan 21,2026
(/) Sales [ ₹696.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.42x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '1.42 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.59x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 0.39x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VENUS REMEDIES | 696.5 | 1.42 | 986.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.04 | 386,905.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.89 | 159,357.0 |
| CIPLA LTD | 28,349.6 | 3.90 | 110,628.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.00 | 134,788.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.78 | 96,441.5 |
| MANKIND PHARMA LTD | 13,576.9 | 6.38 | 86,682.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.60 | 88,156.2 |
| LUPIN LTD | 24,750.7 | 3.95 | 97,727.5 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.00 | 65,145.6 |
| ABBOTT INDIA LTD | 6,714.4 | 8.74 | 58,658.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.42x |
| Max industry PS | 15.89x |
| Median industry PS | 3.95x |
| Average industry PS | 6.06x |
You may also like the below Video Courses